Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet E Yalvac

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Brain and Behavior|August 23, 2017
A novel p.T139M mutation in HSPB1 highlighting the phenotypic spectrum in a familyJakkrit Amornvit, Mehmet E Yalvac, Lei Chen, et al.
Gene Therapy|March 11, 2018
AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse modelMehmet E Yalvac, Jakkrit Amornvit, Lei Chen, et al.
Frontiers in Genetics|April 23, 2021
Adapting CRISPR/Cas9 System for Targeting Mitochondrial GenomeSyed-Rehan A Hussain, Mehmet E Yalvac, Benedict Khoo, et al.
Neurochemical Research|January 27, 2009
Comparison and optimisation of transfection of human dental follicle cells, a novel source of stem cells, with different chemical methods and electro-porationMehmet E Yalvac, Mustafa Ramazanoglu, Osman Z Gumru, et al.
Brain and Behavior|September 22, 2018
Efficacy of exogenous pyruvate in Trembler<sup>J</sup> mouse model of Charcot-Marie-Tooth neuropathyZarife Sahenk, Mehmet E Yalvac, Jakkrit Amornvit, et al.
Current Pharmaceutical Design|November 26, 2009
Potential role of dental stem cells in the cellular therapy of cerebral ischemiaMehmet E Yalvac, Albert A Rizvanov, Ertugrul Kilic, et al.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A/R1Zarife Sahenk, Burcak Ozes, Darren Murrey, et al.
Neurobiology of Disease|May 10, 2023
Impaired motor unit recovery and maintenance in a knock-in mouse model of ALS-associated Kif5a variantKelly A Rich, Megan G Pino, Mehmet E Yalvac, et al.
Skeletal Muscle|December 16, 2017
Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesisMehmet E Yalvac, Jakkrit Amornvit, Cilwyn Braganza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2014
VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathyMehmet E Yalvac, William David Arnold, Syed-Rehan A Hussain, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Brain and Behavior|August 23, 2017
A novel p.T139M mutation in HSPB1 highlighting the phenotypic spectrum in a familyJakkrit Amornvit, Mehmet E Yalvac, Lei Chen, et al.
Gene Therapy|March 11, 2018
AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse modelMehmet E Yalvac, Jakkrit Amornvit, Lei Chen, et al.
Frontiers in Genetics|April 23, 2021
Adapting CRISPR/Cas9 System for Targeting Mitochondrial GenomeSyed-Rehan A Hussain, Mehmet E Yalvac, Benedict Khoo, et al.
Neurochemical Research|January 27, 2009
Comparison and optimisation of transfection of human dental follicle cells, a novel source of stem cells, with different chemical methods and electro-porationMehmet E Yalvac, Mustafa Ramazanoglu, Osman Z Gumru, et al.
Brain and Behavior|September 22, 2018
Efficacy of exogenous pyruvate in Trembler<sup>J</sup> mouse model of Charcot-Marie-Tooth neuropathyZarife Sahenk, Mehmet E Yalvac, Jakkrit Amornvit, et al.
Current Pharmaceutical Design|November 26, 2009
Potential role of dental stem cells in the cellular therapy of cerebral ischemiaMehmet E Yalvac, Albert A Rizvanov, Ertugrul Kilic, et al.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A/R1Zarife Sahenk, Burcak Ozes, Darren Murrey, et al.
Neurobiology of Disease|May 10, 2023
Impaired motor unit recovery and maintenance in a knock-in mouse model of ALS-associated Kif5a variantKelly A Rich, Megan G Pino, Mehmet E Yalvac, et al.
Skeletal Muscle|December 16, 2017
Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesisMehmet E Yalvac, Jakkrit Amornvit, Cilwyn Braganza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2014
VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathyMehmet E Yalvac, William David Arnold, Syed-Rehan A Hussain, et al.
Pageof 2